Skip to main content

Advertisement

SpringerLink
Log in

Mechanisms of ischemic brain injury

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Stroke is the third leading cause of death and the leading cause of long-term disability in the United States. Approximately 80% of all strokes are ischemic and there are limited therapies approved for the treatment of acute ischemic stroke. Understanding the mechanisms of ischemic brain damage is necessary for the development of innovative treatment strategies. In this review, we discuss the hemodynamic and molecular mechanisms of ischemic brain damage and the potential therapeutic strategies, including reperfusion and primary and secondary neuroprotection, and strategies for recovery of function, such as neural plasticity and stem cell transplantation. The effective treatment of ischemic stroke is likely to result from a combination of therapeutic modalities aimed at different mechanisms of ischemic brain damage and delivered at specific times after acute cerebral ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. American Heart Association: 2003 Heart and Stroke Statistical Update. Dallas: American Heart Association; 2003. http:// www.american-heart.org/statistics/05stroke.html. This web site gives the latest epidemiologic data on heart disease and stroke.

    Google Scholar 

  2. Hickenbottom SL, Barsan WG: Acute ischemic stroke therapy. Neurol Clin 2000, 19:379–397.

    Article  Google Scholar 

  3. Neumar RW: Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 2000, 36:483–506.

    PubMed  CAS  Google Scholar 

  4. Iadecola C: Cerebral circulatory dysregulation in ischemia. In Cerebrovascular Diseases, vol 1. Edited by Ginsberg MD, Bogousslavsky J. Cambridge: Blackwell; 1998:319–332.

    Google Scholar 

  5. Baron J: Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999, 9:193–201.

    Article  PubMed  CAS  Google Scholar 

  6. Symon L: Flow thresholds in brain ischemia and the effects of drugs. Br J Anaesth 1985, 57:34–43.

    Article  PubMed  CAS  Google Scholar 

  7. Garcia JH, Lassen NA, Weiller C, et al.: Ischemic stroke and incomplete infarction. Stroke 1996, 27:761–765.

    PubMed  CAS  Google Scholar 

  8. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587. A landmark paper in which the authors showed that IV thrombolysis with rt-PA is safe and effective for the treatment of acute ischemic stroke in selected patients presenting within 3 hours of symptom onset.

    Article  Google Scholar 

  9. Furlan AJ, Higashida RT, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999, 282:2003–2011. An important paper in which the authors showed the effectiveness of IA thrombolysis with r-proUK in patients with acute ischemic stroke presenting within 6 hours of symptom onset.

    Article  PubMed  CAS  Google Scholar 

  10. Qureshi AI, Pande RU, Kim SH, et al.: Third generation thrombolytics for the treatment of ischemic stroke. Curr Opin Investig Drugs 2002, 3:1729–1732.

    PubMed  CAS  Google Scholar 

  11. Leary MC, Saver JL, Gobin YP, et al.: Beyond tissue plasminogen activator: mechanical intervention in acute stroke. Ann Emerg Med 2003, 41:838–846.

    Article  PubMed  Google Scholar 

  12. The Internet Stroke Center: Stroke trials directory. http:// www.strokecenter.org/trials/browse.asp?browse=acute This web site gives an excellent summary of all the ongoing and completed acute ischemic stroke trials.

  13. AbESTT Investigators: Effects of abciximab for acute ischemic stroke: final results of abciximab in emergent stroke treatment trial (AbESTT). Stroke 2003, 34:252.

    Google Scholar 

  14. Iadecola C: Mechanisms of cerebral ischemic damage. In Cerebral Ischemia: Molecular and Cellular Pathophysiology. Edited by Walz W. Totowa, NJ: Humana Press; 1999:3–32.

    Google Scholar 

  15. Hossman KA: Ischemia-mediated neuronal injury. Resuscitation 1993, 26:225–235.

    Article  Google Scholar 

  16. Zhang ZG, Zhang L, Tsang W, et al.: Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002, 22:379–392.

    Article  PubMed  CAS  Google Scholar 

  17. Ivan M, Kondo K, Yang H, et al.: HIF[alpha] targeted for VHL mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464–468.

    PubMed  CAS  Google Scholar 

  18. Croughwell N, Smith LR, Quill T: The effect of temperature on cerebral metabolism and blood flow in adults during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992, 103:549–554.

    PubMed  CAS  Google Scholar 

  19. Baker CJ, Onesti ST, Solomon RA: Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study. J Neurosurg 1992, 77:438–444.

    Article  PubMed  CAS  Google Scholar 

  20. Krieger DW, De Georgia MA, Abou-Chebel A, et al.: Cooling for acute ischemic brain damage (COOL AID). An open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001, 32:1847–1854.

    PubMed  CAS  Google Scholar 

  21. Gelb AW, Bayona NA, Wilson JX, et al.: Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 2002, 96:1183–1190.

    Article  PubMed  CAS  Google Scholar 

  22. Sunami K, Takeda Y, Hashimoto M, et al.: Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med 2000, 28:2831–2836.

    Article  PubMed  CAS  Google Scholar 

  23. Anderson DC, Bottini AG, Jagiella WM, et al.: A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke 1991, 22:1137–1142.

    PubMed  CAS  Google Scholar 

  24. Singhal AB, Dijkhuizen RM, Rosen BR, et al.: Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 2002, 58:945–952.

    PubMed  Google Scholar 

  25. Hansen AJ: Effect of anoxia on ion distribution in the brain. Physiol Rev 1985, 65:101–148.

    PubMed  CAS  Google Scholar 

  26. Hossman KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994, 36:557–565.

    Article  Google Scholar 

  27. Kitagawa K, Matsumoto M, Kuwabara K, et al.: “Ischemic tolerance” phenomenon detected in various brain regions. Brain Res 1991, 561:201–211.

    Article  Google Scholar 

  28. Simpson KL, Lin RCS: Cellular and molecular mechanisms of ischemic tolerance. In New Concepts in Cerebral Ischemia. Edited by Lin RCS. Boca Raton: CRC Press; 2002:263–306.

    Google Scholar 

  29. Kivirikko KI, Myllyharju J: Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol 1998, 16:357–368.

    Article  PubMed  CAS  Google Scholar 

  30. Franklin TJ, Morris WP, Edwards PN, et al.: Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. J. Biochem 2001, 353:333–338.

    Article  CAS  Google Scholar 

  31. Gwag BJ, Won SJ, Kim DY: Excitotoxicity, oxidative stress, and apoptosis in ischemic neuronal death. In New Concepts in Cerebral Ischemia. Edited by Lin RCS. Boca Raton: CRC Press; 2002:79–112. A comprehensive review of glutamate excitotoxicity, calcium-mediated ischemic brain damage, oxygen free radicals, and ischemic injury, and differences between oncosis (swelling necrosis) and apoptosis.

    Google Scholar 

  32. Lees KR: Cerestat and other NMDA antagonists in ischemic stroke. Neurology 1997, 49:S66-S69.

    PubMed  CAS  Google Scholar 

  33. Gladstone DJ, Black SE, Hakim AM, for the Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery: Toward wisdom from failure. Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002, 33:2123–2136. The authors discuss the limitations of the animal models of stroke, the pitfalls in the previous neuroprotective drug trials, and strategies for new therapies.

    Article  PubMed  Google Scholar 

  34. Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001, 21:2–14.

    Article  PubMed  CAS  Google Scholar 

  35. Zhang ZG, Reif D, Macdonald J, et al.: ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1996, 16:599–604.

    Article  PubMed  CAS  Google Scholar 

  36. He YY, Hsu CY, Ezrin AM, et al.: Polyethylene glycolconjugated superoxide dismutase in focal cerebral ischemiareperfusion. Am J Physiol 1993, 265:H252-H256.

    PubMed  CAS  Google Scholar 

  37. Braquet P, Spinnewyn B, Demerle C, et al.: The role of plateletactivating factor in cerebral ischemia and related disorders. Ann N Y Acad Sci 1989, 559:296–312.

    Article  PubMed  CAS  Google Scholar 

  38. Hossman KA: Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol 1994, 4:23–36.

    Article  Google Scholar 

  39. Lascola CD, Kraig RP: Astrocyte reaction in global ischemic brain injury. In Primer in Cerebrovascular Diseases. Edited by Welsh M, Caplan L, Siesjo B, et al. San Diego: Academic Press; 1997:114–117.

    Google Scholar 

  40. Barone FC, Feuerstein GZ: Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999, 19:819–834. A comprehensive review of the role of inflammation in ischemic brain injury. The authors discuss the latest concepts about inflammatory mediators and discuss potential new targets for therapy.

    Article  PubMed  CAS  Google Scholar 

  41. Kumar S, McDonnell PC, Gum RJ, et al.: Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 1997, 235:533–538.

    Article  PubMed  CAS  Google Scholar 

  42. Nogawa S, Zhang F, Ross E, et al.: Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997, 17:2746–2755.

    PubMed  CAS  Google Scholar 

  43. Chen J, Graham SH: Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001, 21:99–109. An excellent review article discussing the mechanisms of apoptotic cell death. The authors also discuss new targets for therapy.

    PubMed  Google Scholar 

  44. Krupinski J, Issa R, Bujny T, et al.: A putative role for platelet derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke 1997, 28:564–573.

    PubMed  CAS  Google Scholar 

  45. Gladstone DJ, Black SE: Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci 2000, 27:97–105.

    PubMed  CAS  Google Scholar 

  46. Hasbani MJ, Schlief ML, Fisher DA, et al.: Dendritic spines lost during glutamate receptor activation reemerge at original sites of synaptic contact. J Neurosci 2001, 21:2393–2403.

    PubMed  CAS  Google Scholar 

  47. Bogousslavsky J, Donnan G: Fibroblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial [abstract]. Cerebrovasc Dis 2000, 10:106.

    Google Scholar 

  48. Clark W, Schim J: Trafermin in acute stroke: results of a phase II/III randomized efficacy study [abstract]. Neurology 2000, 54:A88.

    Google Scholar 

  49. Park KI, Snyder EY: Neural stem cell biology provides insights into new therapeutic strategies for hypoxic-ischemic brain injury. In New Concepts in Cerebral Ischemia. Edited by Lin RCS. Boca Raton: CRC Press; 2002:61–77. The authors discuss in detail the biology of neural stem cells, the concepts behind neural stem cell transplantation, and stem cell-based gene therapy.

    Google Scholar 

  50. Kondziolka D, Wechsler L, Goldstein S, et al.: Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000, 55:565–569.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cerebrovascular Program, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, H 506, 185 South Orange Avenue, 07103, Newark, NJ, USA

    Adnan I. Qureshi MD

Authors
  1. Vallabh Janardhan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adnan I. Qureshi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janardhan, V., Qureshi, A.I. Mechanisms of ischemic brain injury. Curr Cardiol Rep 6, 117–123 (2004). https://doi.org/10.1007/s11886-004-0009-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-004-0009-8

Keywords

Search

Navigation